ABVC BioPharma (ABVC) P/E (2011 - 2026)
ABVC BioPharma (ABVC) P/E from Apr 5, 2011 to Jul 20, 2026. The TTM ABVC BioPharma (ABVC) P/E is -4.25. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ABVC BioPharma (ABVC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.25 | -52.75% |
| 2025 | -8.99 | +517.58% |
| 2024 | -1.46 | +326.75% |
| 2023 | -0.34 | -65.02% |
| 2022 | -0.98 | -86.58% |
| 2021 | -7.27 | -30.60% |
| 2020 | -10.47 | -50.01% |
| 2019 | -20.95 | -70.29% |
| 2018 | -70.51 | -33.88% |
| 2017 | -106.64 | -89.22% |
| 2016 | -989.58 | -101.53% |
| 2015 | 64.88K | -2494116.42% |
| 2014 | -2.60 | N/A |
| 2013 | -2.60 | +861.61% |
| 2012 | -0.27 | -90.40% |
| 2011 | -2.82 | N/A |
Comparison ABVC BioPharma (ABVC) P/E with competitors
ABVC BioPharma (ABVC) P/E is -4.25.